<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=153667366809409&amp;ev=PageView&amp;noscript=1">

Avea Solutions Blog

New White House Budget Retains Majority of Opioid Epidemic Aid Funding


The Trump administration released its proposed 2018 budget today, which rolled back potential budget cuts to the Office of National Drug Control Policy (ONDCP) amid concerns from both parties regarding the effects a reduction could have on the nation's opioid crisis.

Read More

How The AHCA Could Impact Behavioral Health


Yesterday, the Republican-backed health care bill that aims to replace the Affordable Care Act (ACA) passed through the House of Representatives by a narrow margin of 217-213, setting the stage for consideration in the Senate.

Known as the American Health Care Act (AHCA), this bill could have a significant impact within the mental health and addiction recovery treatment industries if passed.

Key Points of the American Health Care Act:

  • The AHCA would move Medicaid funding to a capped payment system, providing states with a set dollar amount for beneficiaries.
  • The bill would do away with ACA-mandated tax penalties on individuals who choose not to buy coverage
  • $130 billion would be devoted to high-risk pools, with the goal of aiding those with serious illnesses to pay high premiums.
  • It would grant states the ability to sign a waiver to opt out of essential health benefits
  • The bill would retain the ability for individuals to remain on family policies until the age of 26, enacted by the ACA.

Some industry figures believe the bill will have a difficult time making it past the next hurdle. In a Behavioral Healthcare Magazine report, Julius Hobson, former head of Congressional relations for the American Medical Association, said, “the reality is the bill that passed the House has no chance of becoming law because the Senate has made it clear it will not pass that bill as is. They will make substantial changes.”

There is also concern that the ACA repeal, coupled with a AHCA bill provision that allows insurance companies in certain states to disallow mental health and substance abuse, could disrupt critical addiction coverage in the midst of the nation's opioid epidemic.

We will continue reporting on industry developments related to the American Health Care Act as information becomes available.


Read More

3 Key Enrollment Facts to Help Free Your Trapped Revenue



Electronic enrollments are tremendously valuable to providers. By offering a more streamlined and secure alternative, these enrollments serve to eliminate many of the headaches caused by paper EOBs. Any opportunity to incorporate automation in your process is certainly worth considering, and electronic enrollments make finding and freeing trapped revenue far easier than any analogue method. 

But if you're unsure whether electronic enrollment is for you, here are some key facts you should know if you're thinking of making the switch: 


Read More

3 Ways to Avoid Falling Victim to Usual & Customary Rate Reductions



Read More

MAT & Long-Term Recovery: A Good Fit?

Buprenorphine and Medication-Assisted Treatment

MAT, short for medication-assisted treatment, is a concept that's gained significant traction within the substance abuse treatment landscape in recent years. The Substance Abuse and Mental Health Services Administration defines MAT as “the use of medications in combination with counseling and behavioral therapies for the treatment of substance use disorders.”[1]  The recent spike in national interest in MAT comes on the heels of a four-fold increase in opioid-related overdose deaths in the United States[2]. While tragic in nature, this epidemic is helping to bring recognition to substance use disorders as a public health concern, prompting policy changes in order to control it. The question now at hand: is MAT the answer to the overdose epidemic? Or for the treatment of substance use disorders in general?

Read More